Contact Person
    Helen Pettersson

    Senior Project Manager
    Email: hp@mva.org
    Phone: (M) +45 2337 0040
    LinkedIn

    MVA Oncology Network Meeting

     

    Welcome to MVA Oncology Network and our 4th meeting
    – a pitch evening with Alligator Bioscience!

    Medicon Valley Alliance Oncology Network set up by prof. and entrepreneur  Nils Brünner (University of Copenhagen) and prof. and entrepreneur Carl Borrebaeck, (Lund University) has now been up and running for one year.

    To celebrate this first succesful year, Medicon Valley Alliance, together with one of our members – Alligator Bioscience, are happy to invite you to the 4th MVA Oncology Network meeting, which will be a full-time pitch and networking evening:
     
    Date: 20 November 2017
    Time: 17:00 – 20:00
    Host: Alligator Bioscience AB
    Venue: Auditorium, Medicon Village, Lund
    Cost: Free of charge for MVA members

    Sign up

    Interested in pitching? Sign up and include a pitch title no later than November 6th.
    To get the chance to be one of the lucky ones selected to present a pitch, you will need to send us a pitch title and short abstract in advance.  If you have any questions, please don’t hesitate to contact Senior Project Manager Helen Pettersson: hp [at] mva.org.

    We are happy to announce that our sponsor HØIBERG offers a free IP strategy meeting with full confidentiality to all groups/projects that will be selected for a pitch.

    In addition, all meeting attendees get the possibility to submit an abstract. All submitted abstracts will be handed out to all meeting attendees, to allow visibility to as many of the attendees as possible.

    The network
    MVA Oncology Network is a professional and social network within oncology. The network focuses on best practice, experience and current challenges for public-private collaboration and the commercialization of oncology related R&D in the Medicon Valley region. The network consists of gprofessors, PI and corporate level executives from the regional oncology eco-system. Membership is limited to Medicon Valley Alliance members only, but non-member organizations and companies are welcome to attend one network event to evaluate if a membership of the network is relevant. If so, becoming a member of Medicon Valley Alliance will automatically able you to join the oncology network.

    Program

    Moderator: Eva Dahlén, Senior Director, Business Developoment, Alligator Bioscience

    17:00-17:30 

    Registration, networking and a bite to eat – meet the fellow participants

    17:30-17.40  Welcome 

    Per Norlén

    CEO
    Alligator Bioscience
    17:40-18.10

    Pitch 1-5: 5 x 5 minute corporate/academic presentations 

    Pitch 1: Transforming personalized oncology by drug-tailored biomarker signatures
    Kristina Masson, Founder and President, OncoSignature

    Pitch 2: Targeting drug resistance
    Nils Brünner; Professor, University of Copenhagen

    Pitch 3: Susscessful Phase I study – Maximun Dose Tolerance in Advanced Cancer Subjects
    Christina Bohlin, Associate Director, Buisness Development, TFS

    Pitch 4: Structure-based design of NF-κB Inducing Kinase (NIK) Inhibitors
    Björn Walse, CEO, SARomics Biostructures AB

    Pitch 5: Finding pre-symptomatic signs of Chemo therapy Induced Peripheral Neuropathy
    Ulf Rogers, Sales and Marketing Manager, Vibrosense Dynamics AB

    18:10-18.50 Structured networking and a light snack
    18:50-19.30

    Pitch 6-10: 5 x 5 minute corporate/academic presentations

    Pitch 6: Superior safety and efficacy by tumor-directed immunotherapy
    Eva Dahlén, Senior Director, Business Developoment, Alligator Bioscience

    Pitch 7: CanFaster – how to mobilize and train tomorrow’s cancer researchers in a triple helix thinking
    Sara Ek, Professor, Head of Department, Lund University

    Pitch 8: KLIFO in support of immuno oncology
    Lisbet Vandvig, Vice President, KLIFO A/S

    Pitch 9: Early Imaging Signal Detection: Use proactive imaging /operation strategies to identify and control risks
    Jane Bentley, Vice President, Clinical Strategy Lead, INC Research/inVentiv Health
    Catherine Klifa, Scientific Liaison Director, Median Technologies

    Pitch 10: Truly Labs, the ideal partner for pre-clinical drug development of your immuno-oncology project
    Matteo Riva, Head of In Vitro Biology, Truly Labs AB

    19:30-20:00 Structured networking and a light snack


    Sponsors

      logo-mv


    In collaboration

    mva logo

    logo LU


    logo uni_copenhagen